• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-28

  Azadi and David examined how PLGA nanoparticle size and surface chemistry shape uptake by human corneal epithelial cells in a mucosa-informed in vitro model. Their results identify energy-dependent endocytosis, especially macropinocytosis and caveolae-mediated uptake, as the predominant routes and provide design principles for topical ocular nanomedicines.

• D-Luciferin for Smarter Glioblastoma BLI

  2026-08-27

  D-Luciferin is a firefly luciferase substrate that turns molecular and cellular events into quantitative light. This guide connects its assay chemistry with glioblastoma delivery research, emphasizing experimental design, readout limitations, and translational interpretation.

• SFRP1, Neutrophils, and Wnt Signaling in Oral Fibrosis

  2026-08-27

  A 2024 mouse and cell study links reduced SFRP1 with neutrophil infiltration, fibrosis, and increased Wnt/β-catenin signaling in arecoline-induced oral submucous fibrosis. SFRP1 overexpression reduced these pathological features, while pathway activation reversed the effect, supporting a mechanistic connection between inflammatory recruitment and fibrotic signaling.

• Alternariol (AOH): A Phenotype-to-Pathway Map

  2026-08-26

  Alternariol (AOH) is a chemically defined probe for connecting mycotoxin exposure with metabolism, cytoskeletal remodeling, apoptosis, and hepatic stellate-cell activation. This guide develops a phenotype-first assay strategy grounded in recent LX-2 omics findings and practical compound-handling decisions.

• Dimetridazole and P. aeruginosa Virulence

  2026-08-26

  Yuan and colleagues showed that Dimetridazole and ribavirin can suppress Pseudomonas aeruginosa virulence-associated phenotypes by perturbing quorum sensing rather than relying solely on direct bacterial killing. Their integrated screening, transcriptomic, combination, and infection-model evidence supports a context-dependent antivirulence strategy while leaving important questions about molecular targets, pharmacology, and clinical transferability.

• Ro 3306: Timing CDK1 to Probe DNA Repair

  2026-08-25

  Ro 3306 is a selective CDK1 inhibitor for controlling mitotic entry and designing cancer cell synchronization experiments. This guide connects temporal CDK1 inhibition with homologous recombination readouts and the emerging TopBP1 inhibitor literature.

• PX-478 in Prenatal Hypoxia-Linked ASD

  2026-08-25

  The reference study used a prenatal hypoxia rat model to test whether pharmacological HIF-1α inhibition could modify autism-like behavioral and hippocampal abnormalities in offspring. PX-478 improved several behavioral outcomes and shifted HIF-1α, PTEN, and VEGF-associated measurements, while the timing of postnatal treatment influenced weight and liver-related safety signals.

• Dorsomorphin 2HCl: AMPK Inhibitor Workflows

  2026-08-24

  Dorsomorphin 2HCl enables pathway-causality testing in metabolic, BMP, osteogenesis, and iron-regulation models. This practical guide connects inhibitor handling with the Lactiplantibacillus plantarum P101 liver study, providing assay design, protocol parameters, and troubleshooting strategies.

• Amikacin Disulfate: From Binding Signal to Assay

  2026-08-23

  Amikacin disulfate is a semisynthetic aminoglycoside antibiotic and a useful probe for connecting protein binding, ribosomal RNA interaction studies, and bacterial protein synthesis suppression. This article develops an assay-centered framework that distinguishes molecular binding from functional inhibition and interprets recent lysozyme evidence without overextending it to ribosomal systems.

• Docosahexaenoic Acid (DHA): Mechanisms and Research Use

  2026-08-22

  Docosahexaenoic Acid (DHA) is an omega-3 membrane lipid enriched in neural and retinal tissues. Current evidence supports structural, signaling, and preclinical neuroprotection research roles, but it does not establish DHA as a vaccine adjuvant or disease treatment.

• ROS Readouts for Adaptive Pancreatic Cancer Therapy

  2026-08-21

  A translational framework for using 2',7'-Dichlorofluorescein diacetate to interpret redox biology in adaptive nanocarrier studies, with practical guidance on assay design, controls, and the limits of general oxidative-stress measurements.

• Oleanolic Acid: Mechanism and Liposome Workflows

  2026-08-20

  Oleanolic acid is a naturally occurring triterpenoid studied for inducible nitric oxide synthase induction, cyclooxygenase-2 modulation, and immune response modulation. A 2025 study also evaluated it in dual-loaded liposomes and reported nanoparticle exclusion chromatography as a robust approach for measuring separation and encapsulation performance.

• Cyclophosphamide: Applied Research Workflows

  2026-08-20

  Build activation-aware cancer and immunology experiments with Cyclophosphamide, from 9L gliosarcoma apoptosis assays to immune-conditioning models. This workflow also translates PK/PD and stratification lessons from an antimicrobial mouse study into stronger assay design and troubleshooting.

• Mechanical Stress and Cytoskeleton-Dependent Autophagy

  2026-08-19

  Liu and colleagues show that compressive mechanical stress induces autophagy through a cytoskeleton-dependent process in human cell lines, with microfilaments acting as the principal structural component and microtubules contributing an auxiliary function. The study connects cytoskeletal mechanics with autophagosome regulation and provides a framework for dissecting mechanotransduction experimentally.

• 3-Methyladenine for Autophagy Assays

  2026-08-19

  Use 3-Methyladenine as a practical perturbation tool for testing autophagy dependence in viability, lysosomal stress, and migration workflows. Its time-dependent effects on class III and class I PI3K make dosing sequence, vehicle control, and orthogonal readouts essential for interpretable results.

458 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page